Bids Are invited for Medicine
Tender Overview
Project Description
Bids Are invited for Tab Anastrazole 1Mg , Tab Aplutamide 60Mg , Tab Bicalutamide 50Mg , Tab Cabozontanib 40 Mg , Tab Capacitabine 500 Mg , Tab Cyclophosphamide 50Mg , Tab Dasatinib 50Mg , Tab Entacavir 0 Point 5Mg , Tab Geftinib 250Mg , Tab Hydroxyurea 500Mg , Tab Lenalidomide 5 Mg , Tab Lenvatinib 4 Mg , Tab Letrazole 2 Point 5 Mg , Tab Nintedanib 150Mg , Tab Nintedanib 100Mg , Tab Nilotinib 200 Mg , Tab Pomalidomide 2 Mg , Tab Relugolix 120 Mg
BOQ
| Sl. No. | Item Title | Item Description |
| 1 | Tab Anastrazole 1mg | Tab Anastrazole 1mg |
| 2 | Tab Aplutamide 60mg | Tab Aplutamide 60mg |
| 3 | Tab Bicalutamide 50mg | Tab Bicalutamide 50mg |
| 4 | Tab Cabozontanib 40 mg | Tab Cabozontanib 40 mg |
| 5 | Tab Capacitabine 500 mg | Tab Capacitabine 500 mg |
| 6 | Tab Cyclophosphamide 50mg | Tab Cyclophosphamide 50mg |
| 7 | Tab Dasatinib 50mg | Tab Dasatinib 50mg |
| 8 | Tab Entacavir 0 point 5mg | Tab Entacavir 0 point 5mg |
| 9 | Tab Geftinib 250mg | Tab Geftinib 250mg |
| 10 | Tab Hydroxyurea 500mg | Tab Hydroxyurea 500mg |
| 11 | Tab Lenalidomide 5 mg | Tab Lenalidomide 5 mg |
| 12 | Tab Lenvatinib 4 mg | Tab Lenvatinib 4 mg |
| 13 | Tab Letrazole 2 point 5 mg | Tab Letrazole 2 point 5 mg |
| 14 | Tab Nintedanib 150mg | Tab Nintedanib 150mg |
| 15 | Tab Nintedanib 100mg | Tab Nintedanib 100mg |
| 16 | Tab Nilotinib 200 mg | Tab Nilotinib 200 mg |
| 17 | Tab Pomalidomide 2 mg | Tab Pomalidomide 2 mg |
| 18 | Tab Relugolix 120 mg | Tab Relugolix 120 mg |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedBid Submission Deadline
Online submission via eProcurement portal.
Upcoming · 11 daysBid Opening Date
Technical bids will be opened and evaluated.
Upcoming · 12 daysTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender